Vistance Networks (VISN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Announced definitive agreement to sell the Connectivity and Cable Solutions (CCS) business to Amphenol for $10.5 billion in cash, with closing expected in the first half of 2026, subject to regulatory and shareholder approval.
Net proceeds after taxes and expenses are expected to be approximately $10 billion, to be used for debt repayment, preferred equity redemption, and a significant dividend to shareholders within 60–90 days post-closing.
Second quarter 2025 net sales reached $1.388 billion, up 32% year over year, with adjusted EBITDA of $338 million, up 79% year over year.
ANS and RUCKUS segments, which will form RemainCo, delivered $513 million in revenue (up 58%) and $127 million in adjusted EBITDA (up 326%) in Q2 2025.
Raised full-year adjusted EBITDA guidance to $1.15–$1.2 billion, reflecting strong segment performance and market recovery.
Voting matters and shareholder proposals
Shareholder approval is required for the CCS sale to Amphenol; a proxy statement will be filed and distributed to stockholders with details.
Directors, executive officers, and certain employees may be considered participants in the proxy solicitation for the transaction.
Board of directors and corporate governance
Information on executive officers and directors is available in the 2024 Annual Report and the March 2025 definitive proxy statement.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025